CSBTF.US Kuros Biosciences AG

Healthcare Health Care Equipment & Supplies USA Stocks
24.09 USD
Close of Nov 13, 2026
22.00 38.91
Market cap
USD 958M
P/E
109.5x
P/B
11.14x
ROE
19.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is CSBTF.US undervalued?

Graham number

The Graham number of Kuros Biosciences AG cannot be estimated reliably (the estimate is too far from the market price).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Kuros Biosciences AG fundamental analysis

No fundamental analysis for Kuros Biosciences AG yet.

Kuros Biosciences AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Kuros Biosciences AG

Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally. It operates through two segments, Medical Devices and Legacy Portfolio. The company provides MagnetOs Granules, an advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold uses to fill bony voids for intervertebral disc space or po…

Full company profile